Latest News, Updates & Breaking Headlines
New Delhi: Swiss drug firm Novartis will sell its entire stake of nearly 71% in its listed Indian subsidiary for about Rs 1,446 crore to a clutch of private equity investors, led by ChrysCapital. The exit comes two years after the parent began a strategic review of its Indian subsidiary, including assessing its stake in…
BENGALURU: Cognizant is learnt to have secured a deal worth over $1 billion from Swiss pharma major Novartis as part of a consolidation contract that includes renewals as well as new scope spanning application services, infrastructure, data and AI-led offerings, people in the know told TOI. This marks the second consecutive billion-dollar deal for Cognizant…
NEW DELHI: The Indian Patent Office (IPO) has revoked the patent on Novartis’ cardiac blockbuster drug Vymada on grounds of lack of novelty, potentially paving the way for affordable generics to enter the market.The popular therapy has been in the spotlight for years, with generic versions from Natco, Torrent Pharma, MSN Labs and Eris Lifesciences…
